아이스큐어 메디컬(ICCM)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $3.02 (+0.67%), 시가총액 $0.02B, 52주 범위 $0.22 ~ $1.19.
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a m
아이스큐어 메디컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
아이스큐어 메디컬의 현재 주가는 $3.02 (+0.67%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
아이스큐어 메디컬의 시가총액은 약 $0.02B입니다.
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the Un